Form 8-K - Current report:
SEC Accession No. 0001564590-22-022465
Filing Date
2022-06-03
Accepted
2022-06-03 16:31:32
Documents
13
Period of Report
2022-05-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K txmd-8k_20220527.htm   iXBRL 8-K 36285
2 EX-3.1 txmd-ex31_10.htm EX-3.1 7761
  Complete submission text file 0001564590-22-022465.txt   174773

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA txmd-20220527.xsd EX-101.SCH 5613
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20220527_lab.xml EX-101.LAB 19320
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20220527_pre.xml EX-101.PRE 11504
7 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8k_20220527_htm.xml XML 3547
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 22994994
SIC: 2834 Pharmaceutical Preparations